Author Correction: Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials

• Bahar Ahani,
• Kevin M. Tuffy,
• Anastasia A. Aksyuk,
• Deidre Wilkins,
• Michael E. Abram,
• Ron Dagan,
• Joseph B. Domachowske,
• Johnathan D. Guest,
• Hong Ji,
• Anna Kushnir,
• Amanda Leach,
• Shabir A. Madhi,
• Vaishali S. Mankad,
• Eric A. F. Simões,
• Benjamin Sparklin,
• Scott D. Speer,
• Ann Marie Stanley,
• David E. Tabor,
• Ulrika Wählby Hamrén,
• Elizabeth J. Kelly,
• Tonya Villafana

Affiliations

Bahar Ahani

Bioinformatics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca

Kevin M. Tuffy

Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca

Anastasia A. Aksyuk

Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca

Deidre Wilkins

Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca

Michael E. Abram

Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca

Ron Dagan

The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences of the Ben-Gurion University of the Negev

Joseph B. Domachowske

State University of New York Upstate Medical University

Johnathan D. Guest

Virology and Vaccine Discovery, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca

Hong Ji

Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca

Anna Kushnir

Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca

Amanda Leach

Clinical Development, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca

Shabir A. Madhi

South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand

Vaishali S. Mankad

Clinical Development, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca

Eric A. F. Simões

University of Colorado School of Medicine and Children’s Hospital Colorado

Benjamin Sparklin

Bioinformatics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca

Scott D. Speer

Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca

Ann Marie Stanley

Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca

David E. Tabor

Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca

Ulrika Wählby Hamrén

Clinical Pharmacology and Quantitative Pharmacology, R&D, AstraZeneca

Elizabeth J. Kelly

Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca

Tonya Villafana

Clinical Development, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca